Introduction With the huge burden of neurological diseases on patients life and society resources, the need of finding and having neuroprotective agents is critical and cost-effective
Estimates for individual agents were consistent with the overall finding: dulaglutide (OR = 0.22, 95% CI 0.160.31), exenatide (OR = 0.26, 95% CI 0.180.37), liraglutide (OR = 0.23, 95% CI 0.180.29), and semaglutide (OR = 0.30, 95% CI 0.200.44)
Well, thats where Fridays comes in
Although it only approves Wegovy to treat obesity
A RECENT study investigating the association between glucagon-like peptide-1 receptor agonists (GLP-1RA) and thyroid cancer in adults with type 2 diabetes has revealed an increased risk of thyroid cancer diagnoses within the first year of starting GLP-1RA therapy